Does a weight-loss shot help protect kidneys in people with heart disease?

Original Title

Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

A medicine called semaglutide, given as a weekly shot, helped protect the kidneys of people who were overweight, had heart disease, but didn’t have diabetes.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

Semaglutide improved kidney function in people who already had early damage.

Chronic kidney disease is usually seen as irreversible. Seeing eGFR *increase*—not just decline slower—is highly unusual in clinical trials.

Practical Takeaways

If you have obesity and heart disease, talk to your doctor about whether semaglutide could help protect your kidneys, even if you don’t have diabetes.

high confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.